Stock Events

Stock Events

Zhongzhi Pharmaceutical Limited 

HK$0.7400
3
+HK$0.04+5.71% Friday 07:35

Statistics

Day High
0.745
Day Low
0.69
52W High
0.98
52W Low
0.5
Volume
368,000
Avg. Volume
373,523
Mkt Cap
639.06M
P/E Ratio
13.38
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jun 25
HK$0.05
Jun 24
HK$0.03
Nov 23
HK$0.06
Jun 23
HK$0.03
Jun 23
HK$0.06
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

20MarExpected
Q1 2017
Q2 2017
Q1 2018
Q4 2023
Q1 2024
Q2 2024
Q4 2024
0
0.02
0.03
0.05
Expected EPS
N/A
Actual EPS
N/A

Financials

1%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.92BRevenue
19.09MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CSPC Pharmaceutical Group Limited.
1093.HK
Mkt Cap102.27B
CSPC Pharmaceutical Group Limited, a major player in the pharmaceutical industry in China, directly competes in the same regional market and therapeutic categories.
Sino Biopharmaceutical
1177.HK
Mkt Cap85.6B
Sino Biopharmaceutical Limited, known for its significant presence in the Chinese pharmaceutical market, offering similar products, particularly in the traditional Chinese medicine segment.
Shanghai Pharmaceuticals.
2607.HK
Mkt Cap76.63B
Shanghai Fosun Pharmaceutical Group Co., Ltd., operates in the same geographical market and has overlapping product lines in pharmaceuticals.
Shanghai Fosun Pharmaceutical (Group).
2196.HK
Mkt Cap104.44B
China Traditional Chinese Medicine Holdings Co. Limited specializes in traditional Chinese medicine, directly competing with Zhongzhi's product offerings.
3SBIO
1530.HK
Mkt Cap20.36B
3SBio Inc., competes in the biotechnology and pharmaceutical sectors in China, offering products that could substitute or compete with Zhongzhi's offerings.
SSY Group Limited
2005.HK
Mkt Cap12.13B
Luye Pharma Group Ltd., operates in the pharmaceutical sector in China with a focus on innovation in drug development, competing in similar therapeutic areas.
Ping An Healthcare And Technology Company Limited
1833.HK
Mkt Cap34.91B
Shineway Pharmaceutical Group Limited, another key competitor in the traditional Chinese medicine sector, directly competes with Zhongzhi in market share and product range.
China Resources Pharmaceutical Group Limited
3320.HK
Mkt Cap42.41B
China Resources Pharmaceutical Group Limited, a large conglomerate in the pharmaceutical industry, competes across various product lines including those offered by Zhongzhi.
China Health Group
8225.HK
Mkt Cap283.68M
Wai Yuen Tong Medicine Holdings Limited, focuses on traditional Chinese medicine, competing directly with Zhongzhi in this niche market.

About

Zhongzhi Pharmaceutical Holdings Limited, an investment holding firm based in the People's Republic of China, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing and distribution. Its operations are structured across three main divisions: pharmaceutical production, management of its physical retail pharmacy chain, and its online pharmacy platform. The company offers Chinese patent medicines and traditional Chinese decoction pieces, marketed under prominent brands such as Zeus, Liumian, and Caojinghua. In addition to its core pharmaceutical activities, Zhongzhi also produces and sells food products and traditional Chinese herbs, manages properties, and offers detection and testing services. By the end of 2021, the company managed a network of 398 self-owned retail pharmacies. Of these, 361 were approved for medical insurance payments and are situated in Zhongshan, Guangdong Province, operating under the Zeus brand. Established in 1993, the company's headquarters are also located in Zhongshan, PRC. Crystal Talent Investment Group Limited holds a controlling stake in Zhongzhi Pharmaceutical Holdings Limited.
Show more...
CEO
Ying Feng Lai
Employees
2284
Country
Cayman Islands
ISIN
KYG989611085

Listings

HK
HK
3737.HK

0 Comments

Share your thoughts

FAQ

What is Zhongzhi Pharmaceutical Limited stock price today?▼
The current price of 3737.HK is HK$0.74 HKD — it has increased by +5.71% in the past 24 hours. Watch Zhongzhi Pharmaceutical Limited stock price performance more closely on the chart.
What is Zhongzhi Pharmaceutical Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange Zhongzhi Pharmaceutical Limited stocks are traded under the ticker 3737.HK.
Is Zhongzhi Pharmaceutical Limited stock price growing?▼
3737.HK stock has risen by +8.82% compared to the previous week, the month change is a +19.35% rise, over the last year Zhongzhi Pharmaceutical Limited has showed a +5.71% increase.
What is Zhongzhi Pharmaceutical Limited market cap?▼
Today Zhongzhi Pharmaceutical Limited has the market capitalization of 639.06M
What is Zhongzhi Pharmaceutical Limited revenue for the last year?▼
Zhongzhi Pharmaceutical Limited revenue for the last year amounts to 1.92B HKD.
What is Zhongzhi Pharmaceutical Limited net income for the last year?▼
3737.HK net income for the last year is 19.09M HKD.
Does Zhongzhi Pharmaceutical Limited pay dividends?▼
Yes, 3737.HK dividends are paid semi-annual. The last dividend per share was 0.05 HKD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Zhongzhi Pharmaceutical Limited have?▼
As of September 06, 2026, the company has 2,284 employees.
In which sector is Zhongzhi Pharmaceutical Limited located?▼
Zhongzhi Pharmaceutical Limited operates in the Health & Wellness sector.
When did Zhongzhi Pharmaceutical Limited complete a stock split?▼
Zhongzhi Pharmaceutical Limited has not had any recent stock splits.
Where is Zhongzhi Pharmaceutical Limited headquartered?▼
Zhongzhi Pharmaceutical Limited is headquartered in Zhongshan, Cayman Islands.